Latest News

Signaling Pathway Sheds Light on Chronic Liver Disease Therapy
Digestive hormone found to reduce liver fibrosis associated with cholestasis.
Protease inhibitors can frequently lead to cardiovascular disease, diabetes, and obesity.
Pharmacists among 301 individuals charged for allegedly engaging in $900 million in false billings.
Study finds a large proportion of breast cancer patients are receiving enough follow-up heart scans.
Findings will allow for improved screenings of drugs that treat MS.
Recent advances and updates in oncology and cancer drug development.
Engineering bacteria to deliver HIV-1 neutralizing antibodies at the site where the virus enters the body may offer a cost-effective barrier to HIV-1 transmission.
“You can put yourself out of business by getting into the specialty pharmacy business.”


Challenges Continue for True Patient-Centered Access
Access to oral chemotherapies is filled with challenges for providers and patients that can be significant, resulting in delayed therapy.
As with care for any chronic condition, the goals for advanced oncology therapies should be improving outcomes, containing costs, and increasing medication adherence.
As new biosimilars enter the market, pharmacies should carefully consider infrastructure, resources, and strategies for successfully integrating the products into their portfolio of offerings.
Despite initiatives that help patients maintain adherence, health care providers still need to leverage their collective resources and work together to overcome this tremendous hurdle in cancer care.

Featured Company Profile

MHA Specialty Pharmacy Solutions: Patient Engagement Strategies for Your Pharmacy


Paul LeVine, vice president of Analytic Services at TrialCard, discusses the use of technology to improve patient care in specialty pharmacy.

Josh Stein, CEO and Co-founder of AdhereTech, discusses how smart pill technology can improve adherence in patients on a specialty drug regimen.

Autumn Bagwell, PharmD, BCPS, clinical pharmacist at Vanderbilt Specialty Pharmacy, discusses the elements of an effective interdisciplinary collaborative patient management program.

Douglas Samojedny, RPh, director of Pharmacy Operations at Pharmacy Advantage, discusses initiatives to optimize medication adherence.

Previous TabNext Tab
Strategic Alliance Partners
Company Profile >
Contributors >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Contact Us
Terms & Conditions
MJH Associates >
Pharmacy Times
American Journal of Managed Care
Targeted Oncology
Physicians' Education Resource
Intellisphere, LLC
666 Plainsboro Road
Building 300
Plainsboro, NJ 08536
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2016
Intellisphere, LLC. All Rights Reserved.